150 related articles for article (PubMed ID: 3026008)
21. Sulbactam kinetics and excretion into breast milk in postpartum women.
Foulds G; Miller RD; Knirsch AK; Thrupp LD
Clin Pharmacol Ther; 1985 Dec; 38(6):692-6. PubMed ID: 2998677
[TBL] [Abstract][Full Text] [Related]
22. Biliary elimination of apalcillin: an experimental and clinical study.
Brogard JM; Arnaud JP; Blickle JF; Dorner M; Lautier F
Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):180-7. PubMed ID: 3710630
[TBL] [Abstract][Full Text] [Related]
23. Biliary elimination of apalcillin in humans.
Brogard JM; Arnaud JP; Blickle JF; Lavillaureix J
Antimicrob Agents Chemother; 1984 Sep; 26(3):428-30. PubMed ID: 6508274
[TBL] [Abstract][Full Text] [Related]
24. The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction.
Wright N; Wise R
J Antimicrob Chemother; 1983 Jun; 11(6):583-7. PubMed ID: 6309731
[TBL] [Abstract][Full Text] [Related]
25. In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus.
Kazmierczak A; Duez JM; Pechinot A; Nordmann P; Labia R
Rev Infect Dis; 1986; 8 Suppl 5():S549-54. PubMed ID: 3026003
[TBL] [Abstract][Full Text] [Related]
26. Penetration of sulbactam into the cerebrospinal fluid of patients with bacterial meningitis receiving ampicillin therapy.
Stahl JP; Bru JP; Fredj G; Brammer KW; Malleret MR; Micoud M
Rev Infect Dis; 1986; 8 Suppl 5():S612-6. PubMed ID: 3026013
[TBL] [Abstract][Full Text] [Related]
27. [Biliary excretion of apalcillin. Experimental study and evaluation in man].
Brogard JM; Adloff M; Pinget M; Dorner M; Lautier F
Pathol Biol (Paris); 1985 Feb; 33(2):121-8. PubMed ID: 3889782
[TBL] [Abstract][Full Text] [Related]
28. [Biliary diffusion of tazocillin in man].
Brogard JM; Caro-Sampara F; Westphal JF; Jehl F
Pathol Biol (Paris); 1999 Oct; 47(8):836-44. PubMed ID: 10573704
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of sulbactam in humans.
Foulds G; Stankewich JP; Marshall DC; O'Brien MM; Hayes SL; Weidler DJ; McMahon FG
Antimicrob Agents Chemother; 1983 May; 23(5):692-9. PubMed ID: 6307133
[TBL] [Abstract][Full Text] [Related]
30. Ampicillin/sulbactam (Unasyn).
Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
[No Abstract] [Full Text] [Related]
31. [Chemotherapy of biliary tract infections (XXIV). Biliary excretion and gallbladder tissue levels of mezlocillin].
Kobayashi N; Tanimura H; Huang WF; Sekiya T; Takahashi H; Sato T; Yoshida K; Hikasa Y
Jpn J Antibiot; 1984 Apr; 37(4):597-604. PubMed ID: 6471380
[TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy of biliary tract infections. XIV. Biliary excretion and gallbladder tissue levels of piperacillin (author's transl)].
Tanimura H; Saito T; Sekiya T; Kobayashi N; Hikasa Y
Jpn J Antibiot; 1981 Oct; 34(10):1401-9. PubMed ID: 6460883
[TBL] [Abstract][Full Text] [Related]
33. [Studies on penetration of antibiotics to gallbladder tissue and bile, its surgical significance. Mainly with cefmenoxime].
Tsuburaya H; Watanabe I; Endo S; Oikawa M
Jpn J Antibiot; 1985 Jan; 38(1):31-40. PubMed ID: 3857360
[TBL] [Abstract][Full Text] [Related]
34. Randomised study of prophylactic parenteral sulbactam/ampicillin and cephazolin in biliary surgery: significant benefit in jaundiced patients.
Morris DL; Jones JA; Harrison JD; Andrews GI; Phillips RJ; Slack RC
J Hosp Infect; 1989 Apr; 13(3):261-6. PubMed ID: 2567755
[TBL] [Abstract][Full Text] [Related]
35. Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery.
Martin C; Cotin A; Giraud A; Beccani-Argème M; Alliot P; Mallet MN; Argème M
Antimicrob Agents Chemother; 1998 May; 42(5):1093-7. PubMed ID: 9593133
[TBL] [Abstract][Full Text] [Related]
36. Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
Davies BI; Maesen FP; van Noord JA
J Antimicrob Chemother; 1984 Feb; 13(2):161-70. PubMed ID: 6323377
[TBL] [Abstract][Full Text] [Related]
37. The value of chemoprophylaxis against Enterococcus species in elective cholecystectomy: a randomized study of cefuroxime vs ampicillin-sulbactam.
Dervisoglou A; Tsiodras S; Kanellakopoulou K; Pinis S; Galanakis N; Pierakakis S; Giannakakis P; Liveranou S; Ntasiou P; Karampali E; Iordanou C; Giamarellou H
Arch Surg; 2006 Dec; 141(12):1162-7. PubMed ID: 17178957
[TBL] [Abstract][Full Text] [Related]
38. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
English AR; Girard D; Cimochowski C; Faiella J; Retsema JA; Lynch JE
Rev Infect Dis; 1986; 8 Suppl 5():S535-42. PubMed ID: 3026002
[TBL] [Abstract][Full Text] [Related]
39. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Campoli-Richards DM; Brogden RN
Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
[TBL] [Abstract][Full Text] [Related]
40. Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery.
Kager L; Malmborg AS; Sjöstedt S; Nord CE
Eur J Clin Microbiol; 1983 Dec; 2(6):559-63. PubMed ID: 6321166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
